Vishal Sikri - 11 May 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: President Advanced Diagnostics
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 11 May 2023
Net transactions value: $0
Form type: 4
Filing time: 15 May 2023, 17:05:53 UTC
Previous filing: 01 Feb 2023
Next filing: 02 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NEO	Common Stock						149,122	11 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+39,683		$0.000000	39,683	11 May 2023	Common Stock	39,683	$19.65	Direct	F4
transaction	NEO	Restricted Stock Unit	Award	$0	+21,204		$0.000000	21,204	11 May 2023	Common Stock	21,204	$0.000000	Direct	F5, F6
transaction	NEO	Performance Stock Unit	Award	$0	+21,204		$0.000000	21,204	11 May 2023	Common Stock	21,204	$0.000000	Direct	F6, F7
holding	NEO	Stock Option (Right to Buy)						319,112	11 May 2023	Common Stock	319,112	$8.42	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This balance includes 442 shares that were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
F2	On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
F3	On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4	On May 11, 2023, Mr. Sikri was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F5	On May 11, 2023, Mr. Sikri was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F6	Once vested, the shares of common stock are not subject to expiration.
F7	On May 11, 2023, Mr. Sikri was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.